Dr. Marcelo Villar, researcher at the Institute of Translational Medicine Research (CONICET - Universidad Austral) and Medical Director of Immunalgia Therapeutics, was interviewed by La Gaceta TV (of Tucumán) about the advances in pain research and the drug that could become the first drug, worldwide, to treat a disease that until now lacks a specific treatment.